BioCentury
ARTICLE | Clinical News

Fycompa perampanel regulatory update

October 29, 2012 7:00 AM UTC

FDA approved epilepsy drug Fycompa perampanel from Eisai as adjunct treatment for partial onset seizures in patients with epilepsy ages >=12 years. The pharma will announce a launch timeline for Fycom...